Harrow Health, Inc. (HROW) Stock Forecast
HROW analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 9 analysts
- Price target
- $65.00 average of analyst targets
- Upside to target
- +138.3% from the latest close
- Next earnings
- November 9, 2026 EPS estimate $0.17
- 52-week range
- $27.24 – $54.80
HROW analyst ratings
9 analystsNumber of analysts at each rating.
HROW price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HROW earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.32 | $0.21 | $0.48 | $0.33 | −3.0% | 4 |
| Current fiscal year (2026) | $0.43 | $0.14 | $0.74 | $0.20 | +116.0% | 3 |
| Next fiscal year (2027) | $2.77 | $2.28 | $3.10 | $0.43 | +539.8% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HROW revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $99.1M | $95.9M | $101.7M | +38.3% | 9 |
| Current fiscal year (2026) | $350.1M | $341.0M | $355.0M | +28.6% | 9 |
| Next fiscal year (2027) | $536.3M | $479.0M | $587.1M | +53.2% | 9 |
HROW EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HROW revenue: reported and forecast
HROW EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.38 | $0.28 | $0.32 | $0.32 | $0.32 | −15.1% | 0 up · 3 down |
| Current fiscal year (2026) | $0.45 | $0.28 | $0.45 | $0.43 | $0.43 | −3.0% | 0 up · 0 down |
| Next fiscal year (2027) | $2.68 | $2.71 | $2.83 | $2.77 | $2.77 | +3.6% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HROW earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HROW beat in 4 of 12.
What analysts expect from HROW
9 analysts cover Harrow Health; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $65.00, 138.3% above the latest close of $27.28. Analysts expect earnings of $0.43 per share for 2026, +116.0% from a year earlier. For 2027 the average estimate is $2.77 per share on revenue of $536.3 million. Harrow Health beat the EPS estimate in 4 of the last 12 quarters.
Related: HROW income statement, HROW key metrics, HROW chart. See the HROW stock overview for the latest quote and news.
HROW forecast FAQ
What is Harrow Health's price target?
The average analyst price target for Harrow Health is $65.00, 138.3% above the latest close of $27.28.
Is Harrow Health a buy, hold or sell?
Of 9 analysts covering Harrow Health, 9 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Harrow Health's EPS forecast?
Analysts forecast $0.43 per share for 2026 (range $0.14 to $0.74); for 2027 the estimate is $2.77.
What is Harrow Health's revenue forecast?
The average revenue estimate for 2026 is $350.1 million, growth of 28.6%; for 2027 it is $536.3 million.
When does Harrow Health report earnings?
Harrow Health is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes; the EPS estimate is $0.17.
Does Harrow Health usually beat earnings estimates?
Harrow Health reported EPS at or above the analyst estimate in 4 of the last 12 quarters.